PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17509533-0	2007	The effect of quercetin phase II metabolism on its MRP1 and MRP2 inhibiting potential.	Quercetin	14-23	ATP binding cassette subfamily C member 1	Homo sapiens	51-55	
17509533-1	2007	The present study characterises the effect of phase II metabolism, especially methylation and glucuronidation, of the model flavonoid quercetin on its capacity to inhibit human MRP1 and MRP2 activity in Sf9 inside-out vesicles.	Quercetin	134-143	ATP binding cassette subfamily C member 1	Homo sapiens	177-181	
17509533-5	2007	Overall, the results of this study reveal that the major phase II metabolites of quercetin are equally potent or even better inhibitors of human MRP1 and MRP2 than quercetin itself.	Quercetin	81-90	ATP binding cassette subfamily C member 1	Homo sapiens	145-149	
17509533-6	2007	This finding indicates that phase II metabolism of quercetin could enhance the potential use of quercetin- or flavonoids in general-as an inhibitor to overcome MRP-mediated multidrug resistance.	Quercetin	51-60	ATP binding cassette subfamily C member 1	Homo sapiens	160-163	
17509533-6	2007	This finding indicates that phase II metabolism of quercetin could enhance the potential use of quercetin- or flavonoids in general-as an inhibitor to overcome MRP-mediated multidrug resistance.	Quercetin	96-105	ATP binding cassette subfamily C member 1	Homo sapiens	160-163